venlafaxine hydrochloride has been researched along with sertraline in 173 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (7.51) | 18.2507 |
| 2000's | 59 (34.10) | 29.6817 |
| 2010's | 78 (45.09) | 24.3611 |
| 2020's | 23 (13.29) | 2.80 |
| Authors | Studies |
|---|---|
| Preskorn, SH | 1 |
| Jaffe, IA | 1 |
| Althof, SE | 1 |
| de Koning, FH; Egberts, AC; Lenderink, AW; Leufkens, HG | 1 |
| Ahern, D; Ball, SE; Kao, J; Scatina, J | 1 |
| Mitchell, S; Tracy, KA; Zajecka, J | 1 |
| Jaffe, IA; Rudikoff, D | 1 |
| Richelson, E | 1 |
| Bagby, RM; Dickens, SE; Joffe, R; Kennedy, SH; Levitt, A; Minifie, CE; Schuller, DR | 1 |
| Gorman, JM | 1 |
| Anand, VS; Dewan, MJ | 1 |
| Hwang, W; Kim, KY; Narendran, R | 1 |
| Alfaro, CL; Ereshefsky, L; Lam, YW; Simpson, J | 1 |
| Behnke, K; Mehtonen, OP; Roponen, P; Søgaard, J | 1 |
| Anisman, H; Griffiths, J; Merali, Z; Ravindran, AV; Zaharia, MD | 1 |
| Harvey, AT; Preskorn, SH; Rudolph, RL | 1 |
| Dunn, NR; Freemantle, SN; Mackay, FR; Mann, RD; Martin, RM; Pearce, GL | 1 |
| Bacchiochi, JR; Bagby, RM; Dickens, SE; Eisfeld, BS; Kennedy, SH | 1 |
| Gottlieb, N | 1 |
| Hostetter, A; Ritchie, JC; Stowe, ZN | 1 |
| Deslandes, PN; Pache, DM; Sewell, RD; Subhan, F | 1 |
| Woods, SW | 1 |
| Sheridan, MJ; Wise, TN | 1 |
| Caputo, RM; Stern, S; Votolato, NA | 1 |
| Fitzgerald, F; Glod, CA; Lynch, A | 1 |
| Cook, IA; Leuchter, AF | 1 |
| Jacob, C; Luckhaus, C | 1 |
| Boskailo, E; Djuric-Bijedic, Z; Lewis, J; Pavkovic, I; Smajkic, A; Weine, S | 1 |
| Boskailo, E; Durić-Bijedić, Z; Lewis, J; Pavković, I; Smajkić, A; Weine, S | 1 |
| Davis, MW; Fisher, AA | 1 |
| Bagby, RM; Kennedy, SH; Vanderkooy, JD | 1 |
| Rickels, K; Rynn, M | 1 |
| Datto, CJ; DiFilippo, S; Katz, IR; Oslin, DW; Streim, JE; Ten Have, TR; Weintraub, D | 1 |
| Cheng, KT; DeVane, CL; Donovan, JL; Liston, HL; Markowitz, JS; Risch, SC; Willard, L | 1 |
| Bateman, DN; Chick, J; Good, AM; Kelly, CA; Masterton, G | 1 |
| Carella, A; Cheok, A; Ginovart, N; Houle, S; Hussey, D; Meyer, JH; Potter, WZ; Sagrati, S; Spencer, EP; Wilson, AA | 1 |
| Bastiaens, L | 1 |
| Cela, R; Garcia-Jares, C; Lamas, JP; Llompart, M; Salgado-Petinal, C | 1 |
| Burt, T; D'Souza, RF; George, T; Hopwood, M; Lam, W; Martin, AJ; Sir, A; Uguz, S; Vahip, S | 1 |
| Fava, M; Mallinckrodt, CH; Martinez, JM; Prakash, A; Watkin, JG; Wohlreich, MM | 1 |
| Giordani, S; Lucca, A; Magri, L; Rossini, D; Smeraldi, E; Zanardi, R | 1 |
| Altshuler, LL; Denicoff, KD; Frye, MA; Grunze, H; Keck, PE; Kupka, RW; Leverich, GS; Martinez, MI; McElroy, SL; Nolen, WA; Post, RM; Suppes, T | 1 |
| Biggs, MM; Fava, M; Luther, JF; Niederehe, G; Nierenberg, AA; Ritz, L; Rush, AJ; Shores-Wilson, K; Stewart, JW; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Higuchi, T; Honda, K; Kamijima, K; Kitahara, S; Tanaka, S; Yamada, M | 1 |
| Asnis, G; Benattia, I; Davidson, J; Musgnung, JJ; Rothbaum, BO; Tucker, P | 1 |
| Akgoz, S; Akkaya, C; Kirli, S; Sarandol, A; Saygin Eker, S; Yazicioglu, B | 1 |
| Altshuler, LL; Denicoff, KD; Frye, MA; Grunze, H; Keck, PE; Kitchen, CM; Kupka, RW; Leverich, GS; McElroy, S; Mintz, J; Nolen, WA; Post, RM; Suppes, T; Walden, J | 1 |
| Eastwood, BJ; Jones, CK; Need, AB; Shannon, HE | 1 |
| Leighton, JA; Luckritz, TC; Patel, BM; Rady, MY; Wells, CD; Zornik, JM | 1 |
| Bremner, JD; Charney, DS; Vermetten, E; Vythilingam, M | 1 |
| Dunner, DL; Haman, KL; Hirschfeld, RM; Kiev, A; Lydiard, RB; Rapaport, MH; Shelton, RC; Smith, WT; Zajecka, JM | 1 |
| Colombo, C; De Ronchi, D; Mandelli, L; Rossini, D; Serretti, A; Tarricone, I; Zanardi, R | 1 |
| Connor, K; Davidson, JR; Vaishnavi, S | 1 |
| Boovariwala, A; Ginovart, N; Houle, S; Meyer, JH; Rusjan, P; Sagrati, S; Sokolov, S; Spencer, EP; Voineskos, AN; Wilson, AA | 1 |
| Benattia, I; Demitrack, M; Entsuah, R; Nemeroff, CB; Sloan, DM; Thase, ME | 1 |
| Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A | 1 |
| Jagadheesan, K; Lusicic, A | 1 |
| Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH | 1 |
| Bonaccorso, S; Girardi, P; Matrisciano, F; Nicoletti, F; Panaccione, I; Ricciardi, A; Ruberto, A; Scaccianoce, S; Shelton, RC; Tatarelli, R; Wang, L | 1 |
| Davis, LL; Fava, M; Luther, JF; Nierenberg, AA; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Buitelaar, JK; Roobol, TH | 1 |
| Muneoka, K; Shioda, S; Shirayama, Y; Takigawa, M | 1 |
| Balch, AH; Berman, RM; Boulton, DW; Mallikaarjun, S; Patel, CG; Reeves, RA; Royzman, K | 1 |
| Bootzin, E; Millan, MJ; O'Donnell, JM; Zhang, HT; Zhao, Z | 1 |
| Altshuler, LL; Black, DO; Frye, MA; Grunze, H; Helleman, G; Keck, PE; Kupka, R; Leverich, GS; McElroy, SL; Mintz, J; Nolen, WA; Post, RM; Suppes, T | 1 |
| Vitiello, B | 1 |
| Altshuler, LL; Frye, MA; Grunze, H; Hellemann, G; Keck, PE; Kupka, RW; Leverich, GS; McElroy, SL; Nolen, WA; Post, RM; Sugar, CA; Suppes, T | 1 |
| Hassan, M; Marcus, SC; Olfson, M | 1 |
| Arnow, BA; Barkin, JL; Dowling, F; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Rothbaum, BO; Trivedi, MH; Wisniewski, SR | 1 |
| Martinez, DN; Martinez, TT | 1 |
| Akkaya, C; Cangur, S; Eker, SS; Kirli, S; Sarandol, A | 1 |
| Laje, G; McMahon, FJ; Perlis, RH; Rush, AJ | 1 |
| Baumer, C; Koren, G; O'Brien, L; Sachs, H; Thieme, D | 1 |
| Drummer, OH; Gerostamoulos, D; Pilgrim, JL | 1 |
| Agius, M; Gardner, J; Liu, K; Zaman, R | 3 |
| Deshpande, A; Ing, A; Rizo, C; Seeman, N | 1 |
| Cooper, NJ; Gordon, E; Koslow, SH; Nemeroff, CB; Rush, AJ; Schatzberg, AF; Williams, LM; Wisniewski, SR | 1 |
| Bartell, SE; Furlong, ET; Logue, A; Painter, MM; Schoenfuss, HL; Schultz, MM; Werner, SL | 1 |
| Beste, J; Blackwell, JC; Patel, BN | 1 |
| Dusetzina, SB; Ellis, AR; Farley, JF; Gaynes, BN; Hansen, RA; Miller, WC; Stürmer, T | 2 |
| Barber, JP; Barrett, MS; Gallop, R; Rickels, K; Rynn, MA | 1 |
| Kocsis, JH | 1 |
| Leelahanaj, T | 1 |
| Fava, M; Perlis, RH; Perroud, N; Uher, R | 1 |
| Eriksson, AC; Hägg, S; Hallbäck, I; Whiss, PA | 1 |
| Adams, J; Graves, N; Solomon, D | 1 |
| Balasubramani, GK; Daly, E; Gaynes, BN; Kurian, BT; Lesser, I; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR | 1 |
| Carlsson, J; Ekstrøm, M; Elklit, A; Mortensen, EL; Sonne, C | 1 |
| Filov, I; Gerazova, VP; Marinov, P; Novotni, A; Ristevska-Dimitrovska, G; Shishkov, R; Stefanovski, B; Vujovik, V | 1 |
| Etkin, A; Gordon, E; Grieve, SM; Harris, A; Korgaonkar, MS; Koslow, SH; Nemeroff, CB; Schatzberg, AF; Williams, LM; Wisniewski, S | 1 |
| Al-Amin, MM; Rahman, MM; Rana, MS; Reza, HM; Uddin, MM | 1 |
| Gibiino, S; Marsano, A; Serretti, A | 1 |
| Roy-Byrne, P | 1 |
| Hoge, EA; Keshaviah, A; Pollack, MH; Simon, NM; Stein, MB; Van Ameringen, M; Worthington, JW | 1 |
| Cooper, N; Gross, JJ; McRae, K; Rekshan, W; Williams, LM | 1 |
| Handley, AP; Williams, M | 1 |
| Abdollahian, E; Azarpazhooh, A; Haghighi, MB; Mokhber, N; Saghebi, A; Samadi, R; Soltanifar, A | 1 |
| Austin, PC; Gomes, T; Ho, JM; Juurlink, DN; Mamdani, M; Straus, SE | 1 |
| Brignone, M; Ereshefsky, L; Francois, C; Lançon, C; Llorca, PM; Rive, B; Salah, S | 1 |
| García Diaz, B; Hidalgo Correas, FJ; Rubio Álvaro, N; Tejedor Prado, P | 1 |
| Ballandonne, C; Dubreule, C; Halm-Lemeille, MP; Kientz-Bouchart, V; Minguez, L; Rakotomalala, C | 1 |
| Etkin, A; Patenaude, B; Rekshan, W; Rush, AJ; Schatzberg, AF; Song, YJ; Usherwood, T; Williams, LM | 1 |
| Arnow, BA; Boyce, PM; Day, CV; DeBattista, C; Etkin, A; Harris, AW; John Rush, A; Rekshan, W; Schatzberg, AF; Williams, LM | 1 |
| Arnow, BA; Blasey, C; Etkin, A; Kulkarni, J; Luther, JF; Palmer, DM; Rekshan, W; Rush, AJ; Schatzberg, AF; Williams, LM | 1 |
| DeBattista, C; Etkin, A; Lazzeroni, LC; Murphy, GM; Schatzberg, AF; Williams, LM | 1 |
| Etkin, A; Grieve, SM; Gyurak, A; Korgaonkar, MS; Patenaude, B; Williams, LM | 1 |
| Banzi, R; Cusi, C; Moja, L; Randazzo, C; Sterzi, R; Tedesco, D | 1 |
| Arns, M; DeBattista, C; deBeuss, R; Etkin, A; Fitzgerald, PB; Gordon, E; Harris, A; Hegerl, U; Palmer, DM; Williams, LM | 1 |
| del Río-Casanova, L; Díaz-Llenderrozas, F; Portela, B | 1 |
| Arns, M; Debattista, C; Fallahpour, K; Fitzgerald, P; Gordon, E; Jongsma, ML; Kenemans, L; Kessels, RP; van Dinteren, R; Williams, LM | 1 |
| Avramescu, ET; Dănciulescu Miulescu, R; Ilie, M; Manda, G; Margină, DM; Neamţu, MC; Purdel, NC | 1 |
| Arns, M; Boutros, NN; Gordon, E | 1 |
| Citrome, L | 1 |
| Etkin, A; Gyurak, A; Harris, A; Shilyansky, C; Usherwood, T; Williams, LM | 1 |
| Bagmetova, VV; Chernysheva, YV; Ozerov, AA; Tyurenkov, IN | 1 |
| Chang, LR; Chen, IM; Chen, TT; Huang, WL; Kuo, TB; Liao, SC; Yang, CC | 1 |
| Hoge, CW; Lee, DJ; Rasmusson, AM; Schnitzlein, CW; Vythilingam, M; Wolf, JP | 1 |
| Gordon, E; Grieve, SM; Korgaonkar, MS; Rush, AJ; Williams, LM | 1 |
| Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
| Brawman-Mintzer, O; Dauphin, M; Gao, J; Geibel, B; Madhoo, M; McIntyre, RS; Richards, C; Sambunaris, A; Weisler, R | 1 |
| Li, Y; Lu, X; Tao, C; Yan, W | 1 |
| Brooks, MM; Luther, JF; Potter, MA; Roberts, MS; Singh, A; Voorhees, RE; Wisniewski, SR | 1 |
| Aalto-Setälä, M; Brignone, M; Campbell, R; Cure, S; Danchenko, N; Diamand, F; Hallinen, T; Kolasa, K; Koponen, H; Soini, E | 1 |
| Adamczak, SK; Bury, TBS; Donovan, EE; Fong, PP; Lambert, OJ; Palmucci, JR | 1 |
| Bech, P; Carlsson, J; Elklit, A; Mortensen, EL; Sonne, C | 1 |
| Melvin, SD | 1 |
| Deshmukh, R; Gill, JS; Jamwal, S; Kumar, P | 1 |
| Chen, J; Deng, X; Fang, L; Lei, T; Lei, Y; Qu, Z; Zhang, L; Zhao, X; Zhong, J; Zhou, C; Zou, B | 1 |
| Broadhouse, K; Gordon, E; Grieve, SM; Koslow, S; Maller, JJ; Rush, AJ | 1 |
| Dmitrzak-Weglarz, M; Kapelski, P; Narozna, B; Pawlak, J; Rajewska-Rager, A; Skibinska, M; Szczepankiewicz, A; Twarowska-Hauser, J | 1 |
| Binder, EB; Carrillo-Roa, T; Craighead, WE; Debattista, C; Dunlop, BW; Goldstein-Piekarski, AN; Mayberg, HS; Nemeroff, CB; O'Connell, CP; Schatzberg, AF; Williams, LM | 1 |
| Floyd, R; Hogue, AN; Lagzdins, M; Saker, F; Scwersenski, J; Temple-Cooper, ME; Worley, S | 1 |
| Bureau, R; Halm-Lemeille, MP; Minguez, L | 1 |
| Banach, E; Dmitrzak-Węglarz, M; Leszczyńska-Rodziewicz, A; Pawlak, J; Szczepankiewicz, A; Twarowska-Hauser, J; Zaremba, D | 1 |
| Carleton, BC; Etminan, M; Guo, MY; Kezouh, A; Kim, DD; Procyshyn, RM; Samii, A | 1 |
| Augustin, M; Franz, C; Gründer, G; Paulzen, M; Saßmannshausen, H; Schoretsanitis, G | 1 |
| Gui, J; Maguen, S; Schnurr, PP; Shiner, B; Watts, BV; Westgate, CL; Young-Xu, Y | 1 |
| Gotlib, IH; Kircanski, K; Williams, LM | 1 |
| Clabault, H; Cohen, M; Sanderson, JT; Vaillancourt, C | 1 |
| Braund, TA; Harris, AWF; Palmer, DM; Williams, LM | 1 |
| Bajbouj, M; Cooper, K; Daly, EJ; Drevets, WC; Hough, D; Lane, R; Lim, P; Manji, H; Mazzucco, C; Molero, P; Popova, V; Shelton, RC; Singh, JB; Thase, ME; Trivedi, M; Vieta, E | 1 |
| Arnold, PD; Bousman, C; Greenslade, A; Maruf, AA | 1 |
| Ameele, HVD; Blier, P; Daly, EJ; Drevets, WC; Fava, M; Fedgchin, M; Gaillard, R; Hough, D; Lane, R; Liebowitz, M; Lim, P; Manji, H; Melkote, R; Preskorn, S; Ravindran, A; Singh, JB; Trivedi, M; Vitagliano, D | 1 |
| Arns, M; Boutros, NN; Fallahpour, K; van der Vinne, N; van Putten, MJAM; Vollebregt, MA | 1 |
| Barata, C; Gómez-Canela, C; Marcé, RM; Martínez-Jerónimo, F; Rovira García, X | 1 |
| Doucet, N; Hudon Thibeault, AA; López de Los Santos, Y; Sanderson, JT; Vaillancourt, C | 1 |
| Fornito, A; Goldstein-Piekarski, AN; Korgaonkar, MS; Williams, LM | 1 |
| Arns, M; van der Vinne, N; van Putten, MJAM; Vollebregt, MA | 1 |
| Bates, DW; Buckeridge, DL; Dixon, WG; Girard, N; Haas, JS; Habib, B; Iqbal, U; Li, J; Sheppard, T; Tamblyn, R | 1 |
| Baker, A; Bisson, JI; Dekker, W; Hoskins, MD | 1 |
| Basu, S; Dass, N; Irvin, J; Keller, AS; Ng, A; Rajpurkar, P; Taylor, Z; Vale, V; Williams, LM; Yang, J | 1 |
| Jain, SB; Jha, MK; Rush, AJ; South, C; Trivedi, MH | 1 |
| de Moraes Costa, G; Mello, CF; Soares Barros, AJ; Zanatta, FB; Ziegelmann, PK | 1 |
| Cornelius, SL; Gui, J; Hoyt, JE; Leonard, CE; Schnurr, PP; Shiner, B; Watts, BV; Young-Xu, Y | 1 |
| Badcock, PB; Bailey, AP; Cox, GR; Hetrick, SE; McKenzie, JE; Meader, N; Merry, SN; Moller, CI; Sharma, V | 1 |
| Haas, DM; Marks, C; Quinney, SK; Silvola, R; Teal, E | 1 |
| Hayes, P; Kelly, D; Lukas, K; McCool, A | 1 |
| Kalisch Ellett, LM; Kassie, GM; Nguyen, TA; Pratt, NL; Roughead, EE | 1 |
| Camino, S; Godoy, A; Smith, J; Strejilevich, SA; Szmulewicz, A | 1 |
| Cipelli, R; Dell'Osso, B; Di Nicola, M; Martinotti, G; Peduto, I; Pugliese, AC; Signorelli, MS; Ventriglio, A | 1 |
| Breitinger, S; Frye, MA; Gardea-Resendez, M; Gerberi, DJ; Nuñez, NA; Park, JH; Singh, B; Veldic, M | 1 |
| Finn, DP; Joshi, A; McClean, PL; Todd, S; Wong-Lin, K | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K | 1 |
| Esfahani, H; Golbaz, S; Nabizadeh, R; Rastkari, N; Yaghmaeian, K; Zamanzadeh, M | 1 |
| Simon, NM; Szuhany, KL | 1 |
| Kelley, L; Laschober, R; Sartor, Z | 1 |
| Chen, M; Fan, J; Guo, C; Liu, W; Liu, Y; Lu, H; Xu, J; Yang, J; Zhang, H | 1 |
| Cao, Q; Rao, Y; Yang, R; Zhao, J | 1 |
| Chroňáková, A; Fedorova, G; Fér, M; Grabic, R; Klement, A; Kočárek, M; Kodešová, R; Nikodem, A; Rieznyk, O; Sadchenko, A; Švecová, H | 1 |
26 review(s) available for venlafaxine hydrochloride and sertraline
| Article | Year |
|---|---|
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1995 |
Pharmacologic treatment of rapid ejaculation.
Topics: 1-Naphthylamine; Adult; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Dose-Response Relationship, Drug; Ejaculation; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Venlafaxine Hydrochloride | 1995 |
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1997 |
Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs.
Topics: 1-Naphthylamine; Antidepressive Agents; Cyclohexanols; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1997 |
The use of newer antidepressants for panic disorder.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Pharmacoeconomic studies of antidepressants: focus on venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Buspirone; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Drug Tolerance; Fluoxetine; Fluvoxamine; Humans; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Psychopharmacologic treatment of adolescent depression.
Topics: Adolescent; Child; Cyclohexanols; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2001 |
Pharmacotherapy of generalized anxiety disorder.
Topics: Algorithms; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Humans; Paroxetine; Psychotherapeutic Processes; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2008 |
Specificity profile of venlafaxine and sertraline in major depression: metaregression of double-blind, randomized clinical trials.
Topics: Adrenergic Uptake Inhibitors; Cyclohexanols; Demography; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Randomized Controlled Trials as Topic; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2014 |
The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
Topics: Adult; Aged; Citalopram; Desvenlafaxine Succinate; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vasomotor System; Venlafaxine Hydrochloride | 2015 |
Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies.
Topics: Acetamides; Adult; Aged; Antidepressive Agents; Benzofurans; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Humans; Hypnotics and Sedatives; Indoles; Male; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulfides; Thiophenes; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2014 |
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Topics: Adrenergic Uptake Inhibitors; Adult; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Norepinephrine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Tension-Type Headache; Venlafaxine Hydrochloride | 2015 |
[Venlafaxine-induced delirium mediated by high doses].
Topics: Aged; Antidepressive Agents; Comorbidity; Confusion; Delirium; Depressive Disorder, Major; Dopamine; Dose-Response Relationship, Drug; Drug Substitution; Drug Synergism; Female; Humans; Lorazepam; Models, Neurological; Norepinephrine; Polypharmacy; Psychotropic Drugs; Recurrence; Sertraline; Venlafaxine Hydrochloride | 2015 |
Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Vilazodone Hydrochloride | 2016 |
PSYCHOTHERAPY VERSUS PHARMACOTHERAPY FOR POSTTRAUMATIC STRESS DISORDER: SYSTEMIC REVIEW AND META-ANALYSES TO DETERMINE FIRST-LINE TREATMENTS.
Topics: Antidepressive Agents; Combined Modality Therapy; Humans; Piperazines; Psychotherapy; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression.
Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Clinical Trials as Topic; Data Interpretation, Statistical; Depression; Humans; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Venlafaxine Hydrochloride | 2017 |
Antidepressant pharmacogenetics in children and young adults: A systematic review.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mental Disorders; Nortriptyline; Paroxetine; Pharmacogenetics; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tryptophan Hydroxylase; Venlafaxine Hydrochloride; Young Adult | 2019 |
Pharmacological treatments for adults with post-traumatic stress disorder: A network meta-analysis of comparative efficacy and acceptability.
Topics: Adult; Humans; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Sertraline; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2020 |
New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Antidepressive Agents; Bias; Child; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mirtazapine; Network Meta-Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicidal Ideation; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2021 |
Are all antidepressants the same? The consumer has a point.
Topics: Antidepressive Agents; Bupropion; Citalopram; Fluoxetine; Humans; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2023 |
Short Term Second-Generation Antidepressant Monotherapy in Acute Depressive Episodes of Bipolar II Disorder: A Systematic Review and Meta-Analysis.
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Depression; Humans; Lithium; Randomized Controlled Trials as Topic; Sertraline; Venlafaxine Hydrochloride | 2022 |
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
Anxiety Disorders: A Review.
Topics: Adult; Anxiety Disorders; Cognitive Behavioral Therapy; Humans; Quality of Life; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; United States; Venlafaxine Hydrochloride | 2022 |
Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Fluoxetine; Humans; Imipramine; Network Meta-Analysis; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2022 |
55 trial(s) available for venlafaxine hydrochloride and sertraline
| Article | Year |
|---|---|
Differential pharmacological treatment response in high angry hostile and low angry hostile depressed patients: a retrospective analysis.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Analysis of Variance; Anger; Cyclohexanols; Depressive Disorder; Desipramine; Female; Hostility; Humans; Male; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations.
Topics: Chromatography, High Pressure Liquid; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Dextrorphan; Fluoxetine; Humans; Isoenzymes; Paroxetine; Phenotype; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
Topics: Adult; Aged; Ambulatory Care; Cyclohexanols; Depressive Disorder; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Fluoxetine; Humans; Immune Tolerance; Lymphocyte Activation; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Venlafaxine Hydrochloride | 2000 |
Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms.
Topics: Adult; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents.
Topics: Aged; Aged, 80 and over; Cyclohexanols; Depressive Disorder; Female; Frail Elderly; Geriatric Assessment; Humans; Male; Middle Aged; Nursing Homes; Patient Dropouts; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.
Topics: Administration, Oral; Adult; Alprazolam; Area Under Curve; Breath Tests; Carbon Radioisotopes; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Drug Administration Schedule; Erythromycin; Fluoxetine; Half-Life; Humans; Male; Middle Aged; Molecular Probes; Piperazines; Sertraline; Triazoles; Venlafaxine Hydrochloride | 2004 |
Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.
Topics: Adult; Ambulatory Care; Blood Pressure; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Health Status; Humans; Male; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Substance Withdrawal Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial.
Topics: Adult; Citalopram; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Transcranial Magnetic Stimulation; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Bupropion; Cohort Studies; Cross-Sectional Studies; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Lithium; Male; Psychiatric Status Rating Scales; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Failure; Venlafaxine Hydrochloride | 2006 |
Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2006 |
A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: a randomized, open-labeled clinical trial.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Cyclohexanols; Depressive Disorder, Major; Drug Evaluation; Drug Interactions; Female; Humans; Male; Middle Aged; Morpholines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Venlafaxine Hydrochloride | 2006 |
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
Topics: Adjuvants, Pharmaceutic; Adult; Affect; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Risk Factors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.
Topics: Adult; Antidepressive Agents; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.
Topics: Adult; Antidepressive Agents; Citalopram; Corpus Striatum; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Venlafaxine Hydrochloride | 2007 |
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment | 2008 |
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.
Topics: Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Cyclohexanols; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Female; Humans; Linear Models; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Humans; Middle Aged; Personality Inventory; Primary Health Care; Prognosis; Retreatment; Secondary Prevention; Sertraline; Venlafaxine Hydrochloride | 2008 |
The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Quinolones; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2010 |
Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.
Topics: Acute Disease; Adult; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Bupropion; Cyclohexanols; Demography; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Pharmacogenetics studies in STAR*D: strengths, limitations, and results.
Topics: Adult; Biomarkers; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Humans; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Receptors, Kainic Acid; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Australia; Citalopram; Cognition; Cyclohexanols; Decision Support Techniques; Depressive Disorder, Major; Electroencephalography; Emotions; Europe; Female; Humans; Male; Middle Aged; Neuropsychological Tests; New Zealand; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Behavior; Time Factors; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2011 |
Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Ethnicity; Female; Humans; Male; Middle Aged; Patient Dropouts; Psychiatric Status Rating Scales; Psychotherapy, Brief; Sertraline; Sex Characteristics; Venlafaxine Hydrochloride | 2012 |
Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Female; Humans; Likelihood Functions; Male; Middle Aged; Personality Inventory; Psychometrics; Quality of Life; Sertraline; United States; Venlafaxine Hydrochloride; Young Adult | 2012 |
Increase in work productivity of depressed individuals with improvement in depressive symptom severity.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depression; Drug Therapy, Combination; Efficiency; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Work; Young Adult | 2013 |
Treatment of traumatized refugees with sertraline versus venlafaxine in combination with psychotherapy - study protocol for a randomized clinical trial.
Topics: Clinical Protocols; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Denmark; Humans; Psychiatric Status Rating Scales; Refugees; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Brain; California; Citalopram; Clinical Protocols; Cognition; Cyclohexanols; Depressive Disorder, Major; Diffusion Tensor Imaging; Emotions; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; New South Wales; Predictive Value of Tests; Prospective Studies; Psychiatric Status Rating Scales; Research Design; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Clonazepam; Cyclohexanols; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phobic Disorders; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Effects of antidepressant medication on emotion regulation in depressed patients: an iSPOT-D report.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Emotions; Female; Humans; Male; Middle Aged; Repression, Psychology; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2014 |
Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Antidepressive Agents; Cognition; Comorbidity; Depressive Disorder, Major; Desipramine; Double-Blind Method; Female; Humans; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Cognition; Computers; Delayed-Action Preparations; Depressive Disorder, Major; Emotions; Female; Humans; Male; Middle Aged; Prognosis; Psychiatric Status Rating Scales; Psychological Tests; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
Impairment and distress patterns distinguishing the melancholic depression subtype: an iSPOT-D report.
Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Risk Factors; Sertraline; Symptom Assessment; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
Topics: Adult; Antidepressive Agents; Anxiety; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Outpatients; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
Topics: Adult; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Genotype; Humans; Logistic Models; Male; Middle Aged; Polymorphism, Single Nucleotide; Remission Induction; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
Topics: Adult; Antidepressive Agents; Australia; Citalopram; Cognition; Depressive Disorder, Major; Executive Function; Female; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Prefrontal Cortex; Prognosis; Psychiatric Status Rating Scales; Regression Analysis; Remission Induction; Sertraline; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2016 |
Frontal and rostral anterior cingulate (rACC) theta EEG in depression: implications for treatment outcome?
Topics: Adult; Antidepressive Agents; Brain Mapping; Citalopram; Depressive Disorder, Major; Electroencephalography; Female; Frontal Lobe; Gyrus Cinguli; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Sertraline; Severity of Illness Index; Theta Rhythm; Venlafaxine Hydrochloride | 2015 |
Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Brain; Brain Mapping; Citalopram; Depressive Disorder, Major; Electroencephalography; Evoked Potentials; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Prospective Studies; Sertraline; Sex Characteristics; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
EEG Abnormalities Are Associated With Poorer Depressive Symptom Outcomes With Escitalopram and Venlafaxine-XR, but Not Sertraline: Results From the Multicenter Randomized iSPOT-D Study.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depression; Electroencephalography; Female; Humans; Internationality; Male; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2017 |
Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Cognitive Dysfunction; Depression; Female; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2016 |
Prediction of nonremission to antidepressant therapy using diffusion tensor imaging.
Topics: Adult; Antidepressive Agents; Brain; Citalopram; Delayed-Action Preparations; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nerve Net; Predictive Value of Tests; Psychiatric Status Rating Scales; Sertraline; Venlafaxine Hydrochloride; White Matter; Young Adult | 2016 |
Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Least-Squares Analysis; Lisdexamfetamine Dimesylate; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
Cost-Effective Drug Switch Options After Unsuccessful Treatment With an SSRI for Depression.
Topics: Adult; Bupropion; Citalopram; Cost-Benefit Analysis; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2017 |
Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Denmark; Depression; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Refugees; Research Design; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression.
Topics: Adult; Age Factors; Antidepressive Agents; Citalopram; Cohort Studies; Delayed-Action Preparations; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Hippocampus; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Organ Size; Pattern Recognition, Automated; Prognosis; Psychiatric Status Rating Scales; Remission Induction; Sertraline; Venlafaxine Hydrochloride | 2018 |
Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Carrier Proteins; Citalopram; Depression; Female; Genotype; Homozygote; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2018 |
Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Biomarkers; Citalopram; Depression; Depressive Disorder, Major; Female; Heart Rate; Humans; Male; Middle Aged; Prognosis; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2019 |
Dimensions of anxiety in Major depressive disorder and their use in predicting antidepressant treatment outcome: an iSPOT-D report.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Citalopram; Cognition; Depressive Disorder, Major; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2020 |
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
Topics: Administration, Intranasal; Administration, Oral; Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Ketamine; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2019 |
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
Topics: Administration, Intranasal; Administration, Oral; Adolescent; Adult; Antidepressive Agents; Citalopram; Delayed-Action Preparations; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Ketamine; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2019 |
Normalization of EEG in depression after antidepressant treatment with sertraline? A preliminary report.
Topics: Adult; Alpha Rhythm; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Electroencephalography; Female; Humans; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2019 |
Intrinsic connectomes are a predictive biomarker of remission in major depressive disorder.
Topics: Adult; Antidepressive Agents; Biomarkers; Brain; Citalopram; Connectome; Depressive Disorder, Major; Female; Humans; Magnetic Resonance Imaging; Male; Neural Pathways; Remission Induction; Sertraline; Venlafaxine Hydrochloride; Young Adult | 2020 |
Stability of frontal alpha asymmetry in depressed patients during antidepressant treatment.
Topics: Adult; Alpha Rhythm; Antidepressive Agents; Biomarkers; Citalopram; Depressive Disorder, Major; Electroencephalography; Female; Frontal Lobe; Functional Laterality; Humans; Male; Prospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2019 |
Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Topics: Adult; Algorithms; Antidepressive Agents; Citalopram; Clinical Decision Rules; Depressive Disorder, Major; Electroencephalography; Female; Humans; Machine Learning; Male; Middle Aged; Prognosis; Prospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2020 |
What to Expect When Switching to a Second Antidepressant Medication Following an Ineffective Initial SSRI: A Report From the Randomized Clinical STAR*D Study.
Topics: Adult; Antidepressive Agents; Bupropion; Delayed-Action Preparations; Depressive Disorder, Major; Drug Substitution; Female; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2020 |
92 other study(ies) available for venlafaxine hydrochloride and sertraline
| Article | Year |
|---|---|
Serotonin reuptake inhibitors in Raynaud's phenomenon.
Topics: 1-Naphthylamine; Adult; Aged; Cyclohexanols; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Raynaud Disease; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1995 |
Channeling of three newly introduced antidepressants to patients not responding satisfactorily to previous treatment.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Utilization; Humans; Mianserin; Middle Aged; Mirtazapine; Netherlands; Sertraline; Venlafaxine Hydrochloride | 1997 |
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Fluoxetine; Fluvoxamine; Frozen Sections; Humans; Hydroxylation; Imipramine; In Vitro Techniques; Lethal Dose 50; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Venlafaxine Hydrochloride | 1997 |
Erythromelalgia: response to serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Cyclohexanols; Erythromelalgia; Female; Fluoxetine; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1997 |
Evaluating the tolerability of the newer antidepressants.
Topics: Antidepressive Agents; Bupropion; Central Nervous System Diseases; Citalopram; Cyclohexanols; Delayed-Action Preparations; Drug Information Services; Fluvoxamine; Gastrointestinal Diseases; Guidelines as Topic; Humans; Incidence; Paroxetine; Piperazines; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles; United States; United States Agency for Healthcare Research and Quality; Venlafaxine Hydrochloride | 1999 |
Acute liver damage possibly related to sertraline and venlafaxine ingestion.
Topics: Acute Disease; Adult; Antidepressive Agents; Cephalexin; Cephalosporins; Chemical and Drug Induced Liver Injury; Cyclohexanols; Drug Overdose; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide, Attempted; Venlafaxine Hydrochloride | 1999 |
Evidence of the dual mechanisms of action of venlafaxine.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Biological Transport, Active; Blood Platelets; Blood Pressure; Cyclohexanols; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Humans; Injections, Intravenous; Male; Maprotiline; Middle Aged; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Systole; Tyramine; Venlafaxine Hydrochloride | 2000 |
Newer antidepressants: a comparison of tolerability in general practice.
Topics: Adult; Aged; Antidepressive Agents; Cohort Studies; Cyclohexanols; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1999 |
Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
Topics: Adult; Cyclohexanols; Depressive Disorder; Female; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Ontario; Orgasm; Paroxetine; Prevalence; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Sexual Dysfunctions, Psychological; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Nonhormonal agents show promise against hot flashes.
Topics: Antidepressive Agents, Second-Generation; Antihypertensive Agents; Clonidine; Contraindications; Controlled Clinical Trials as Topic; Cyclohexanols; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Male; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women.
Topics: Adult; Amniotic Fluid; Antidepressive Agents; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cyclohexanols; Female; Fetal Blood; Fluvoxamine; Humans; Pregnancy; Sertraline; Spectrophotometry, Ultraviolet; Venlafaxine Hydrochloride | 2000 |
Do antidepressants affect motivation in conditioned place preference?
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Cocaine; Conditioning, Psychological; Cyclobutanes; Cyclohexanols; Dose-Response Relationship, Drug; Fluoxetine; Male; Motivation; Norepinephrine; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Venlafaxine versus sertraline for major depressive disorder.
Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Serotonergic antidepressants and urinary incontinence.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Female; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Urinary Incontinence; Venlafaxine Hydrochloride | 2000 |
Fluoxetine (Sarafem) for premenstrual dysphoric disorder.
Topics: Adult; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Nausea; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Weight Gain | 2001 |
Prefrontal changes and treatment response prediction in depression.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder, Major; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Prefrontal Cortex; Sertraline; Venlafaxine Hydrochloride | 2001 |
Venlafaxine withdrawal syndrome not prevented by maprotiline, but resolved by sertraline.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Maprotiline; Nausea; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2001 |
Sertralilne, paroxetine and venlafaxine in refugee post traumatic stress disorder with depression symptoms.
Topics: Adult; Antidepressive Agents; Bosnia and Herzegovina; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; United States; Venlafaxine Hydrochloride; Warfare | 2001 |
Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction.
Topics: Accidental Falls; Adult; Aged; Basal Ganglia Diseases; Cyclohexanols; Depressive Disorder; Dopamine Antagonists; Drug Interactions; Female; Humans; Metoclopramide; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline; Tibial Fractures; Venlafaxine Hydrochloride | 2002 |
Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Bupropion; Canada; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Doxepin; Drug Overdose; Drug Prescriptions; Emergency Service, Hospital; Female; Fluoxetine; Humans; Imipramine; Information Services; Male; Mianserin; Mirtazapine; Paroxetine; Patient Admission; Patient Readmission; Poison Control Centers; Retrospective Studies; Risk Assessment; Scotland; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Trazodone; Venlafaxine Hydrochloride | 2004 |
Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
Topics: Adult; Benzylamines; Carbon Radioisotopes; Carrier Proteins; Citalopram; Corpus Striatum; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tomography, Emission-Computed; Venlafaxine Hydrochloride | 2004 |
Adolescents' response to antidepressant treatment in a community mental health center.
Topics: Adolescent; Adolescent Psychiatry; Algorithms; Antidepressive Agents; Child; Child Psychiatry; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Mirtazapine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Solid Phase Microextraction; Venlafaxine Hydrochloride | 2005 |
An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Sertraline; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Induction of neuroserpin expression in rat frontal cortex after chronic antidepressant treatment and electroconvulsive treatment.
Topics: Animals; Antidepressive Agents; Cyclohexanols; Electroconvulsive Therapy; Expressed Sequence Tags; Fluoxetine; Frontal Lobe; Imipramine; Male; Neuropeptides; Neuroserpin; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Serpins; Sertraline; Venlafaxine Hydrochloride | 2006 |
Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
Topics: Adrenergic Uptake Inhibitors; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Chemistry; Carrageenan; Cyclohexanols; Desipramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Duloxetine Hydrochloride; Edema; Fluoxetine; Hot Temperature; Hyperalgesia; Male; Norepinephrine; Paroxetine; Pressure; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Thiophenes; Venlafaxine Hydrochloride | 2006 |
Bezoar formation requiring endoscopic removal after intentional overdose of extended-release nifedipine.
Topics: Anticholesteremic Agents; Antidepressive Agents; Atorvastatin; Bezoars; Calcium Channel Blockers; Cyclohexanols; Delayed-Action Preparations; Drug Overdose; Endoscopy, Digestive System; Fatal Outcome; Female; Heptanoic Acids; Humans; Middle Aged; Nifedipine; Pyrroles; Radiography; Sertraline; Stomach; Venlafaxine Hydrochloride | 2006 |
Effects of antidepressant treatment on neural correlates of emotional and neutral declarative verbal memory in depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Emotions; Female; Fluoxetine; Frontal Lobe; Gyrus Cinguli; Humans; Male; Mental Recall; Middle Aged; Paired-Associate Learning; Personality Inventory; Positron-Emission Tomography; Semantics; Sertraline; Venlafaxine Hydrochloride; Wechsler Scales | 2007 |
Antidepressant response in the elderly.
Topics: Adult; Age Factors; Aged; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials.
Topics: Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Kava; Mianserin; Mirtazapine; Paroxetine; Psychometrics; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2007 |
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Sertraline versus venlafaxine XR in major depressive disorder.
Topics: Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2007 |
[A place for SSRIs in the treatment of severely depressed children and adolescents].
Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide; Venlafaxine Hydrochloride | 2008 |
Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Cyclohexanols; Cyclopropanes; Dopamine; Duloxetine Hydrochloride; Homovanillic Acid; Male; Milnacipran; Norepinephrine; Organ Specificity; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2009 |
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Cyclohexanols; Depression; Down-Regulation; Fenclonine; Male; Monoamine Oxidase Inhibitors; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Protein Synthesis Inhibitors; Protriptyline; Rats; Rats, Sprague-Dawley; Reboxetine; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Sertraline; Venlafaxine Hydrochloride | 2009 |
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.
Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Bupropion; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risk Factors; Sertraline; Statistics as Topic; Venlafaxine Hydrochloride; Young Adult | 2009 |
Recent NIMH clinical trials and implications for practice.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Mental Disorders; Methylphenidate; Multicenter Studies as Topic; National Institute of Mental Health (U.S.); Obsessive-Compulsive Disorder; Psychotropic Drugs; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2008 |
Antidepressant switching among adherent patients treated for depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug Administration Schedule; Humans; Mianserin; Middle Aged; Mirtazapine; Patient Compliance; Sertraline; Trazodone; Venlafaxine Hydrochloride; Young Adult | 2009 |
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy.
Topics: Adolescent; Adult; Age of Onset; Aged; Algorithms; Antidepressive Agents; Anxiety Disorders; Bupropion; Child; Child Abuse, Sexual; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Life Change Events; Male; Mianserin; Middle Aged; Mirtazapine; Parenting; Risk Factors; Self Concept; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
A case of serotonin syndrome associated with methadone overdose.
Topics: Adult; Cyclohexanols; Drug Overdose; Humans; Male; Methadone; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline; Suicide, Attempted; Venlafaxine Hydrochloride | 2008 |
Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?
Topics: Adrenergic Uptake Inhibitors; Adult; Age Factors; Antidepressive Agents; Climacteric; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Middle Aged; Morpholines; Personality Inventory; Reboxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Young Adult | 2009 |
Changes in antidepressant metabolism in pregnancy evidenced by metabolic ratios in hair: a novel approach.
Topics: Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Female; Fluoxetine; Gas Chromatography-Mass Spectrometry; Hair; Humans; Postpartum Period; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Third; Sertraline; Venlafaxine Hydrochloride | 2010 |
Deaths involving serotonergic drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Australia; Cause of Death; Citalopram; Cyclohexanols; Female; Fluoxetine; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Serotonin Agents; Sertraline; Tramadol; Venlafaxine Hydrochloride | 2010 |
An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Comorbidity; Cyclohexanols; Depressive Disorder; England; Fluoxetine; Guideline Adherence; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Practice Patterns, Physicians'; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder; England; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Data Collection; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Fatigue; Fluvoxamine; Humans; Internet; Lethargy; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Stages; Thiophenes; Venlafaxine Hydrochloride | 2011 |
Was Cipriani right? Audits to compare discharge rates and suicidality between antidepressant monotherapies used in a British community mental health team.
Topics: Antidepressive Agents; Citalopram; Community Mental Health Services; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Medical Audit; Mianserin; Mirtazapine; Outcome Assessment, Health Care; Patient Discharge; Sertraline; Suicidal Ideation; Suicide; Suicide Prevention; Treatment Outcome; United Kingdom; Venlafaxine Hydrochloride | 2010 |
Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows.
Topics: Animals; Antidepressive Agents; Brain; Bupropion; Cyclohexanols; Cyprinidae; Endocrine Disruptors; Female; Fluoxetine; Male; Reproduction; Sertraline; Testis; Venlafaxine Hydrochloride; Vitellogenins; Water Pollutants, Chemical | 2011 |
Antidepressant use during pregnancy. FPIN’s clinical inquiries.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Evidence-Based Medicine; Female; Fluoxetine; Humans; Odds Ratio; Paroxetine; Physicians, Family; Pregnancy; Pregnancy Complications; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2011 |
Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?
Topics: Adult; Bias; Bupropion; Buspirone; Cluster Analysis; Cyclohexanols; Depressive Disorder; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Questions raised by the failure of a trial of short-term psychodynamic therapy versus pharmacotherapy for major depressive disorder.
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Drug Approval; Female; Humans; Male; Psychotherapy, Brief; Randomized Controlled Trials as Topic; Sertraline; United States Food and Drug Administration; Venlafaxine Hydrochloride | 2012 |
Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
Topics: Adult; Antidepressive Agents; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Models, Economic; Quality of Life; Sertraline; Thailand; Venlafaxine Hydrochloride | 2012 |
Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Humans; Intention; Male; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Personality Inventory; Primary Health Care; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Sertraline; Suicidal Ideation; Suicide, Attempted; Thinking; Venlafaxine Hydrochloride | 2012 |
In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Blood Coagulation; Blood Platelets; Citalopram; Cyclohexanols; Female; Fibrinogen; Humans; Male; Middle Aged; Morpholines; Norepinephrine; Platelet Adhesiveness; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Venlafaxine Hydrochloride; Young Adult | 2012 |
Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Australia; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Humans; Hypericum; Markov Chains; Middle Aged; Models, Economic; Phytotherapy; Plant Preparations; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Different serum BDNF levels in depression: results from BDNF studies in FYR Macedonia and Bulgaria.
Topics: Adult; Aged; Brain-Derived Neurotrophic Factor; Bulgaria; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Republic of North Macedonia; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Effect of diclofenac and antidepressants on the inflammatory response in astrocyte cell culture.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Astrocytes; Cells, Cultured; Cyclohexanols; Diclofenac; Enzyme-Linked Immunosorbent Assay; Fluvoxamine; Interleukin-10; Lipopolysaccharides; Mice; Pyridoxine; Selective Serotonin Reuptake Inhibitors; Sertraline; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2013 |
Treatment in nonresponsive patients with social anxiety: back to the future with benzodiazepines.
Topics: Anti-Anxiety Agents; Clonazepam; Cyclohexanols; Female; Humans; Male; Phobic Disorders; Sertraline; Venlafaxine Hydrochloride | 2014 |
Adverse cardiac events in older patients receiving venlafaxine: a population-based study.
Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cohort Studies; Comorbidity; Cyclohexanols; Drug Interactions; Female; Heart Failure; Humans; Hypertension; Male; Myocardial Infarction; Ontario; Retrospective Studies; Risk Factors; Sertraline; Tachycardia; Venlafaxine Hydrochloride | 2014 |
[Serious QT interval prolongation associated with velafaxine administration].
Topics: Acute Coronary Syndrome; Adult; Antidepressive Agents; Cardiovascular Agents; Diagnostic Errors; Drug Substitution; Electrocardiography; Humans; Long QT Syndrome; Male; Sertraline; Sodium Channel Blockers; Tachycardia, Sinus; Venlafaxine Hydrochloride | 2014 |
Transgenerational effects of two antidepressants (sertraline and venlafaxine) on Daphnia magna life history traits.
Topics: Animals; Antidepressive Agents; Daphnia; Environment; Female; Fertility; Maternal Exposure; Population Dynamics; Reproduction; Sertraline; Venlafaxine Hydrochloride | 2015 |
Studies regarding the protective effects exhibited by antidepressants on cell models.
Topics: Antidepressive Agents; Antioxidants; Cell Membrane; Depressive Disorder; Dose-Response Relationship, Drug; Erythrocytes; Female; Fluoxetine; Glucosephosphate Dehydrogenase; Humans; Immune System; Lipid Peroxidation; Middle Aged; Oxidative Stress; Sertraline; U937 Cells; Venlafaxine Hydrochloride | 2015 |
Comparison of the Efficiency of Adeprophen and Antidepressants of Various Groups on the Model of Reserpine-Induced Depression in Rats.
Topics: Adenine; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Imipramine; Male; Motor Activity; Paroxetine; Rats; Reserpine; Sertraline; Venlafaxine Hydrochloride | 2016 |
The Effects of Antidepressants and Quetiapine on Heart Rate Variability.
Topics: Adult; Aged; Antidepressive Agents; Anxiety; Depression; Female; Heart Rate; Humans; Linear Models; Male; Medically Unexplained Symptoms; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Sertraline; Taiwan; Venlafaxine Hydrochloride | 2016 |
Effect of antidepressants on spatial memory deficit induced by dizocilpine.
Topics: Animals; Antidepressive Agents; Cell Count; Citalopram; Cognition; Cognitive Dysfunction; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fluvoxamine; Hippocampus; Interneurons; Male; Maze Learning; Memory Disorders; Mianserin; Mirtazapine; Paroxetine; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Sertraline; Spatial Memory; Venlafaxine Hydrochloride | 2016 |
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland.
Topics: Acetamides; Antidepressive Agents; Bupropion; Cost-Benefit Analysis; Decision Trees; Depressive Disorder, Major; Finland; Humans; Markov Chains; Models, Theoretical; Piperazines; Recurrence; Sertraline; Sulfides; Treatment Outcome; Venlafaxine Hydrochloride; Vortioxetine | 2017 |
Exposure to SSRI-type antidepressants increases righting time in the marine snail Ilyanassa obsoleta.
Topics: Animals; Antidepressive Agents; Fluoxetine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Snails; Venlafaxine Hydrochloride | 2017 |
Effect of antidepressants on circadian rhythms in fish: Insights and implications regarding the design of behavioural toxicity tests.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Circadian Rhythm; Cyprinodontiformes; Fluoxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Toxicity Tests; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2017 |
Sertraline and venlafaxine improves motor performance and neurobehavioral deficit in quinolinic acid induced Huntington's like symptoms in rats: Possible neurotransmitters modulation.
Topics: Animals; Corpus Striatum; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamic Acid; Huntington Disease; Interleukin-1beta; Interleukin-6; Lipid Peroxidation; Male; Motor Activity; Neuroprotective Agents; Neurotransmitter Agents; Oxidative Stress; Quinolinic Acid; Rats; Rats, Wistar; Rotarod Performance Test; Sertraline; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2017 |
Brain-derived neurotrophic factor (BDNF) serum level in women with first-episode depression, correlation with clinical and metabolic parameters.
Topics: Adult; Biomarkers; Brain-Derived Neurotrophic Factor; Cross-Sectional Studies; Depression; Female; Humans; Longitudinal Studies; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2018 |
Effects of in-utero exposure to selective serotonin reuptake inhibitors and venlafaxine on term and preterm infants.
Topics: Adult; Apgar Score; Birth Weight; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Length of Stay; Male; Oxygen; Oxygen Inhalation Therapy; Patient Admission; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Term Birth; Venlafaxine Hydrochloride | 2017 |
Joint effects of nine antidepressants on Raphidocelis subcapitata and Skeletonema marinoi: A matter of amine functional groups.
Topics: Amines; Antidepressive Agents; Chlorophyta; Diatoms; Fluoxetine; Sertraline; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2018 |
Venlafaxine and sertraline does not affect the expression of genes regulating stress response in female MDD patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; Humans; Middle Aged; Real-Time Polymerase Chain Reaction; Receptors, Glucocorticoid; Sertraline; Severity of Illness Index; Venlafaxine Hydrochloride; Young Adult | 2017 |
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
Topics: Antidepressive Agents; Basal Ganglia Diseases; Bupropion; Case-Control Studies; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pharmacoepidemiology; Sertraline; United States; Venlafaxine Hydrochloride | 2018 |
Antidepressants in breast milk; comparative analysis of excretion ratios.
Topics: Adult; Antidepressive Agents; Breast Feeding; Child Development; Citalopram; Depression; Female; Humans; Infant; Milk, Human; Pregnancy; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Young Adult | 2019 |
A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice.
Topics: Adult; Anticonvulsants; Female; Fluoxetine; Humans; Male; Medical Records; Middle Aged; Outpatients; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Topiramate; Treatment Outcome; United States; United States Department of Veterans Affairs; Venlafaxine Hydrochloride | 2018 |
Effects of selective serotonin-reuptake inhibitors (SSRIs) in JEG-3 and HIPEC cell models of the extravillous trophoblast.
Topics: ADAM10 Protein; Amyloid Precursor Protein Secretases; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Choriocarcinoma; Female; Fluoxetine; Gene Expression; Humans; Matrix Metalloproteinase 9; Membrane Proteins; Models, Biological; Pregnancy; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Sertraline; Tissue Inhibitor of Metalloproteinase-1; Trophoblasts; Venlafaxine Hydrochloride | 2018 |
Analysis of neurotransmitters in Daphnia magna affected by neuroactive pharmaceuticals using liquid chromatography-high resolution mass spectrometry.
Topics: Animals; Aquatic Organisms; Chromatography, High Pressure Liquid; Daphnia; Duloxetine Hydrochloride; Fluoxetine; Mass Spectrometry; Models, Animal; Neurotransmitter Agents; Sertraline; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2019 |
Serotonin and serotonin reuptake inhibitors alter placental aromatase.
Topics: Aromatase; Cells, Cultured; Citalopram; Female; Fluoxetine; Humans; Molecular Docking Simulation; Paroxetine; Placenta; Pregnancy; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Trophoblasts; Venlafaxine Hydrochloride | 2019 |
Multinational Investigation of Fracture Risk with Antidepressant Use by Class, Drug, and Indication.
Topics: Aged; Antidepressive Agents; Depression; Female; Fractures, Bone; Humans; Male; North America; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Taiwan; United Kingdom; Venlafaxine Hydrochloride | 2020 |
Evidence-based prescribing for post-traumatic stress disorder.
Topics: Evidence-Based Medicine; Fluoxetine; Humans; Paroxetine; Sertraline; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2020 |
Comparing Medications for DSM-5 PTSD in Routine VA Practice.
Topics: Acute Disease; Adult; Carbonic Anhydrase Inhibitors; Female; Fluoxetine; Humans; Male; Medication Adherence; Outcome Assessment, Health Care; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Topiramate; United States; United States Department of Veterans Affairs; Venlafaxine Hydrochloride | 2020 |
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study.
Topics: Antidepressive Agents; Bupropion; Citalopram; Duloxetine Hydrochloride; Escitalopram; Female; Fluoxetine; Humans; Infant, Newborn; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2021 |
Antidepressant medication prescribing patterns in Irish general practice from 2016 to 2020 to assess for long-term use.
Topics: Antidepressive Agents; Drug Prescriptions; Fluoxetine; General Practice; Humans; Practice Patterns, Physicians'; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2022 |
The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study.
Topics: Aged; Antidepressive Agents; Australia; Case-Control Studies; Central Nervous System; Citalopram; Delirium; Fluvoxamine; Humans; Mirtazapine; Nitrazepam; Risk Factors; Sertraline; Venlafaxine Hydrochloride | 2022 |
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Humans; Italy; Paroxetine; Retrospective Studies; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals.
Topics: Aged; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Depression; Donepezil; Dothiepin; Frontotemporal Dementia; Hospitals; Humans; Lamotrigine; Memantine; Mirtazapine; NAD; Sertraline; Valproic Acid; Venlafaxine Hydrochloride; Wales | 2022 |
Occurrence and removal of psychiatric pharmaceuticals in the Tehran South Municipal Wastewater Treatment Plant.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Citalopram; Environmental Monitoring; Humans; Hypnotics and Sedatives; Iran; Pharmaceutical Preparations; Sertraline; Thioridazine; Venlafaxine Hydrochloride; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification | 2023 |
Posttraumatic Stress Disorder: Evaluation and Treatment.
Topics: Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2023 |
Estimating the prevalence of depression using wastewater-based epidemiology: A case study in Qinghai Province, West China.
Topics: Antidepressive Agents; China; Depression; Paroxetine; Prevalence; Sertraline; Venlafaxine Hydrochloride; Wastewater; Water Pollutants, Chemical | 2023 |
Contamination of water, soil, and plants by micropollutants from reclaimed wastewater and sludge from a wastewater treatment plant.
Topics: Carbamazepine; Citalopram; Gabapentin; Humans; Sertraline; Sewage; Soil; Soil Pollutants; Telmisartan; Tramadol; Vegetables; Venlafaxine Hydrochloride; Wastewater; Water | 2024 |